Finance

Beta
Lists
CYP:ASX
Cynata Therapeutics Ltd
A$0.28
0.00%
(0.00) 1D
Jun 5, 4:10:02 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CYP...
Open
A$0.30
High
A$0.30
Low
A$0.28
Mkt. cap
70.62M
Avg. vol.
387.92K
Volume
59.50K
52-wk high
A$0.44
52-wk low
A$0.14
EPS
-A$0.04
Shares outstanding
243.45M
No. of employees
0
Open
A$0.30
High
A$0.30
Low
A$0.28
Mkt. cap
70.62M
Avg. vol.
387.92K
Volume
59.50K
52-wk high
A$0.44
52-wk low
A$0.14
EPS
-A$0.04
Shares outstanding
243.45M
No. of employees
0
News stories
From sources across the web
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
SectorBiotechnology
Websitecynata.com
Last report
Feb 3, 2026
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
886.14K / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-42.49K
-42.49K
886.14K
886.14K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.70M
3.70M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-1.17M
-1.17M
1.69M
1.69M
Operating expense
2.94M
2.94M
2.22M
2.22M
Total operating expenses
2.94M
2.94M
2.22M
2.22M
Operating income
-2.98M
-2.98M
-1.33M
-1.33M
Other non operating income
-
-
-
-
EBT including unusual items
-2.87M
-2.87M
-1.33M
-1.33M
EBT excluding unusual items
-2.87M
-2.87M
-1.33M
-1.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
278.28K
278.28K
425.31K
425.31K
Net income
-2.87M
-2.87M
-1.33M
-1.33M
Net profit margin
6,754.99%
6,754.99%
-150.23%
-150.23%
Earnings per share
-
-
-
-
Interest and investment income
113.85K
113.85K
-
-
Interest expense
-
-
-
-
Net interest expenses
113.85K
113.85K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91M
-2.91M
-1.27M
-1.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer